Abstract

INTRODUCTION: Dialysis patients historically have had poor pregnancy outcomes, but these have improved over the years with better delivery of dialysis care. The purpose of our study is to describe baseline characteristics and pregnancy outcomes among women with end stage renal disease (ESRD) on hemodialysis (HD). METHODS: We carried out a cohort study on all births using the United States' Healthcare Cost and Utilization Project-Nationwide Inpatient Sample database between 2005 and 2015. Descriptive statistics were used to measure baseline characteristics and maternal and neonatal outcomes of women with ESRD under HD treatment. We created a composite measure of vascular mediated adverse pregnancy outcomes which included intrauterine growth restriction (IUGR), preeclampsia and intrauterine fetal death (IUFD). Then, using this composite measure, multivariate logistic regression analyses were used to identify risk factors for the development of vascular mediated adverse outcomes of pregnancy among women with ESRD who were on HD. RESULTS: We identified 307 birth records to women with a ESRD on HD among 8,765,973 births. There was an increase in the number of patients with ESRD on HR over the 10-year study period. None of the baseline characteristics were found to be significantly correlated to the occurrence of the composite outcome. CONCLUSION: The incidence of pregnant women with ESRD on HD in the US is rising, with adverse pregnancy complications for both the mother and fetus. Since no specific predictors for the adverse outcomes were found, this entire group of patients should be considered at high risk, strengthening the need for an early multidisciplinary team management.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call